Changeflow GovPing Healthcare Dry Cellulose-Reinforced Hydrogels for Implants
Routine Notice Added Final

Dry Cellulose-Reinforced Hydrogels for Implants

Favicon for changeflow.com USPTO Patent Applications - Prosthetics (A61F)
Published
Detected
Email

Summary

The USPTO has published a patent application (US20260083565A1) for dry cellulose-reinforced hydrogels designed for implants that rehydrate in situ. The application details a hydrogel implant that can be inserted into the body and allowed to rehydrate within the patient.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a patent application from the USPTO detailing a novel hydrogel implant technology. The invention involves dry cellulose-reinforced hydrogels that include a cellulose nanofiber network and a dry interstitial hydrogel portion. The key innovation is the ability of the implant to be inserted in a dry state and rehydrate within the body.

This patent application is primarily of interest to medical device manufacturers and researchers in the field of biomaterials and implants. While it does not impose immediate regulatory obligations, it signals potential future developments in implantable medical technologies. Companies in this space should monitor patent filings and related innovations to stay abreast of emerging technologies that could impact product development and intellectual property landscapes.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

DRY HYDROGEL IMPLANTS

Application US20260083565A1 Kind: A1 Mar 26, 2026

Inventors

Benjamin J. WILEY, Dushyanth SURAKANTI

Abstract

Dry cellulose-reinforced hydrogels may include a cellulose nanofiber network and an interstitial hydrogel portion within interstitial regions of the cellulose nanofiber network, the interstitial hydrogel portion comprising a hydrogel that is dry. The dry hydrogel implant may be inserted into the body and allowed to rehydrate in situ.

CPC Classifications

A61F 2/30756 A61F 2/3094 A61L 27/16 A61L 27/20 A61L 27/52 A61F 2002/30751 A61F 2002/3084 A61L 2430/02

Filing Date

2023-09-19

Application No.

19113420

View original document →

Named provisions

Abstract Inventors CPC Classifications

Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
September 19th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083565A1

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing 3254 Pharmaceutical Manufacturing
Activity scope
Medical Device Development
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Medical Devices Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!